• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖对乳腺癌的影响:一项回顾性研究。

The impact of obesity on breast cancer: a retrospective review.

机构信息

Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.

出版信息

Ann Surg Oncol. 2012 Sep;19(9):3012-8. doi: 10.1245/s10434-012-2320-8. Epub 2012 Mar 27.

DOI:10.1245/s10434-012-2320-8
PMID:22451232
Abstract

BACKGROUND

Obesity has been linked to many adverse health consequences, including breast cancer; however, the impact on clinical presentation, tumor characteristics, and survival outcomes has yet to be clearly defined.

METHODS

Retrospective review of a prospectively collected database of patients treated at a single institution for invasive breast cancer from 2000-2008 comparing two groups: nonobese (body mass index of <30) and obese (body mass index of ≥ 30) patients. Continuous variables, categorical variables, and survival data were analyzed.

RESULTS

Of 1352 total patients, 76% were classified as nonobese and 24% were obese. When comparing age, obese patients presented less frequently than nonobese patients <50 years old (10% vs. 90%), and when comparing patients >50 years old (18% vs. 82%, P = 0.0019). Obese patients were more likely to present with disease detected by imaging when compared to nonobese patients (67% vs. 56%, P = 0.0006). Obese patients had larger tumors (1.7 cm vs. 1.4 cm, P < 0.001) and higher rates of lymph node (LN) metastases (31% vs. 25%, P = 0.026). On multivariate analysis, obesity was associated with nonpalpable tumors, larger tumors, a higher incidence of LN metastasis, lower incidence of Her2 positivity, lower incidence of multifocality, and less likely to undergo reconstruction after mastectomy.

CONCLUSIONS

Obese patients clinically present at older ages with mammographically detected breast cancer at more advanced stages than nonobese patients. Strategies to encourage screening among the obese patient population are important.

摘要

背景

肥胖与许多不良健康后果有关,包括乳腺癌;然而,其对临床表现、肿瘤特征和生存结果的影响尚未明确界定。

方法

回顾性分析了 2000 年至 2008 年在一家机构接受浸润性乳腺癌治疗的患者的前瞻性收集数据库,比较了两组患者:非肥胖组(体重指数<30)和肥胖组(体重指数≥30)。分析了连续变量、分类变量和生存数据。

结果

在 1352 例总患者中,76%被归类为非肥胖患者,24%为肥胖患者。比较<50 岁的患者时,肥胖患者比非肥胖患者较少出现(10%比 90%,P=0.0019);比较>50 岁的患者时,肥胖患者比非肥胖患者更有可能通过影像学发现疾病(67%比 56%,P=0.0006)。与非肥胖患者相比,肥胖患者的肿瘤更大(1.7 厘米比 1.4 厘米,P<0.001),淋巴结(LN)转移的发生率更高(31%比 25%,P=0.026)。多变量分析显示,肥胖与不可触及的肿瘤、更大的肿瘤、更高的 LN 转移发生率、更低的 Her2 阳性率、更低的多灶性发生率以及乳房切除术后重建的可能性较低相关。

结论

肥胖患者的临床表现年龄较大,且通过乳房 X 线照相术发现的乳腺癌比非肥胖患者更处于晚期。鼓励肥胖患者进行筛查的策略非常重要。

相似文献

1
The impact of obesity on breast cancer: a retrospective review.肥胖对乳腺癌的影响:一项回顾性研究。
Ann Surg Oncol. 2012 Sep;19(9):3012-8. doi: 10.1245/s10434-012-2320-8. Epub 2012 Mar 27.
2
Impact of the obesity on lymph node status in operable breast cancer patients.肥胖对可手术乳腺癌患者淋巴结状态的影响。
J BUON. 2013 Oct-Dec;18(4):824-30.
3
Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.纯黏液性乳腺癌与浸润性导管癌的结局比较:来自中国的一项基于人群的研究。
Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.
4
The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.多灶/多中心肿瘤对乳腺癌患者无病生存的重要性:单中心经验。
Am J Clin Oncol. 2012 Dec;35(6):580-6. doi: 10.1097/COC.0b013e31822d9cd6.
5
Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.采用保乳手术治疗的不可触及与可触及浸润性乳腺癌
Am Surg. 1996 May;62(5):395-9.
6
[Clinical characteristics and prognosis of different subtypes of breast cancer].[乳腺癌不同亚型的临床特征与预后]
Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):456-61.
7
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.不同内在型乳腺癌亚型新辅助化疗后病理完全缓解对预后的定义和影响。
J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.
8
Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.年轻与 HER2 阳性/ER 阴性亚型患者保乳手术后和放射治疗后的同侧乳房肿瘤复发相关。
Breast Cancer Res Treat. 2011 Nov;130(2):499-505. doi: 10.1007/s10549-011-1736-3. Epub 2011 Aug 19.
9
The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.肥胖对采用现代扩展活检方案诊断前列腺癌的影响。
J Urol. 2009 Feb;181(2):574-7; discussion 578. doi: 10.1016/j.juro.2008.10.028. Epub 2008 Dec 13.
10
Does obesity have an effect on outcomes in triple-negative breast cancer?肥胖是否对三阴性乳腺癌的结局有影响?
J Surg Res. 2013 Sep;184(1):253-9. doi: 10.1016/j.jss.2013.05.037. Epub 2013 Jun 2.

引用本文的文献

1
Metabolic landscape of disseminated cancer dormancy.播散性癌症休眠的代谢格局
Trends Cancer. 2025 Apr;11(4):321-333. doi: 10.1016/j.trecan.2024.10.005. Epub 2024 Nov 7.
2
Obesity-Associated Breast Cancer: Analysis of Risk Factors and Current Clinical Evaluation.肥胖相关性乳腺癌:危险因素分析与临床评估现状。
Adv Exp Med Biol. 2024;1460:767-819. doi: 10.1007/978-3-031-63657-8_26.
3
Identification of lysyl oxidase as an adipocyte-secreted mediator that promotes a partial mesenchymal-to-epithelial transition in MDA-MB-231 cells.
鉴定赖氨酰氧化酶为一种脂肪细胞分泌的介质,它可促进MDA-MB-231细胞发生部分间充质-上皮转化。
Explor Target Antitumor Ther. 2024;5(1):1-19. doi: 10.37349/etat.2024.00201. Epub 2024 Jan 16.
4
Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway.利拉鲁肽通过抑制PI3K/Akt/mTOR信号通路减轻肥胖相关乳腺癌细胞的增殖。
Saudi Pharm J. 2024 Jan;32(1):101923. doi: 10.1016/j.jsps.2023.101923. Epub 2023 Dec 18.
5
Does body mass index influence surgical options and overall survival in breast cancer patients?体重指数会影响乳腺癌患者的手术选择和总体生存吗?
Clin Transl Oncol. 2023 Oct;25(10):2922-2930. doi: 10.1007/s12094-023-03154-0. Epub 2023 Apr 4.
6
Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis.诊断后体脂肪、体重变化与乳腺癌预后:全球癌症更新计划(CUP global)系统文献回顾与荟萃分析。
Int J Cancer. 2023 Feb 15;152(4):572-599. doi: 10.1002/ijc.34322. Epub 2022 Oct 24.
7
Peroxisome Proliferator-Activated Receptors and the Hallmarks of Cancer.过氧化物酶体增殖物激活受体与癌症的特征。
Cells. 2022 Aug 5;11(15):2432. doi: 10.3390/cells11152432.
8
The obesity-breast cancer link: a multidisciplinary perspective.肥胖与乳腺癌的关联:多学科视角。
Cancer Metastasis Rev. 2022 Sep;41(3):607-625. doi: 10.1007/s10555-022-10043-5. Epub 2022 Jun 25.
9
Body Mass Index and Breast and Cervical Cancer Screening.体重指数与乳腺癌和宫颈癌筛查。
Womens Health Rep (New Rochelle). 2022 May 9;3(1):508-514. doi: 10.1089/whr.2021.0062. eCollection 2022.
10
Pre-treatment high body mass index is associated with poor survival in Asian premenopausal women with localized breast cancer.治疗前高体重指数与亚洲绝经前局部乳腺癌女性的不良生存相关。
J Cancer. 2021 May 27;12(15):4488-4496. doi: 10.7150/jca.59133. eCollection 2021.